Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia

Chidamide in Combination With DCAG With or Without Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia

ABSTRACT Introduction Currently, there are only a few avaailable treatment options for patients with relapsed and refractory acute myeloid leukemia (R/R AML). Methods We conducted a single‐center, phase 1 prospective study (ChiCTR2200065634) to evaluate the efficacy and safety of chidamide, demethyl...

Full description

Bibliographic Details
Main Authors: Qingyang Liu, Xiawei Zhang, Lei Lv, Linming Xu, Yu Jing, Wenjing Gao, Lili Wang, Liping Dou
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Cancer Medicine
Subjects:
acute myeloid leukemia
chemotherapy
conventional
induction therapy
Venetoclax
Online Access:https://doi.org/10.1002/cam4.70734

Internet

https://doi.org/10.1002/cam4.70734

Similar Items